Drug Trial News

RSS
Xylitol 'gummy bears' may prevent dental problems

Xylitol 'gummy bears' may prevent dental problems

Study shows emergency physicians have good first instincts in diagnosing heart attacks

Study shows emergency physicians have good first instincts in diagnosing heart attacks

Energy drinks associated with risk-taking behaviors among college students

Energy drinks associated with risk-taking behaviors among college students

Raltegravir drug combo works against highly resistant strain of HIV

Raltegravir drug combo works against highly resistant strain of HIV

Statins appear to improve survival in kidney transplant recipients

Statins appear to improve survival in kidney transplant recipients

Endurance exercise makes heart younger

Endurance exercise makes heart younger

First-of-its-kind study examines whether fat tissues from different areas of the body vary in stem cell concentration

First-of-its-kind study examines whether fat tissues from different areas of the body vary in stem cell concentration

Sorafenib extends life of advanced liver cancer patients

Sorafenib extends life of advanced liver cancer patients

Making patients move requires the right exercise advice

Making patients move requires the right exercise advice

Fish oil supplements could slow wound healing

Fish oil supplements could slow wound healing

Medical blogs can pose threat to patient privacy

Medical blogs can pose threat to patient privacy

No doubt: sun causes melanomas

No doubt: sun causes melanomas

PET-CT scanners detect secondary head and neck cancers

PET-CT scanners detect secondary head and neck cancers

New study finds working age adults with major chronic conditions grew 25 percent over 10 years

New study finds working age adults with major chronic conditions grew 25 percent over 10 years

Coronary heart disease linked to problems with reasoning, vocabulary and verbal fluency

Coronary heart disease linked to problems with reasoning, vocabulary and verbal fluency

Gilead initiates phase III trial of Elvitegravir

Gilead initiates phase III trial of Elvitegravir

End of life physician-patient communication

End of life physician-patient communication

Tattoos - who gets rid of them and why

Tattoos - who gets rid of them and why

Epilepsy drug may raise the risk of birth defects

Epilepsy drug may raise the risk of birth defects

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

Trial of treatment of inflammatory bowel disease begins at Tel Aviv Sourasky Medical Center

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.